These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 25240419)

  • 1. Computational insights into function and inhibition of fatty acid amide hydrolase.
    Palermo G; Rothlisberger U; Cavalli A; De Vivo M
    Eur J Med Chem; 2015 Feb; 91():15-26. PubMed ID: 25240419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Keys to Lipid Selection in Fatty Acid Amide Hydrolase Catalysis: Structural Flexibility, Gating Residues and Multiple Binding Pockets.
    Palermo G; Bauer I; Campomanes P; Cavalli A; Armirotti A; Girotto S; Rothlisberger U; De Vivo M
    PLoS Comput Biol; 2015 Jun; 11(6):e1004231. PubMed ID: 26111155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anandamide hydrolysis in FAAH reveals a dual strategy for efficient enzyme-assisted amide bond cleavage via nitrogen inversion.
    Palermo G; Campomanes P; Cavalli A; Rothlisberger U; De Vivo M
    J Phys Chem B; 2015 Jan; 119(3):789-801. PubMed ID: 25205244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The fatty acid amide hydrolase (FAAH).
    Deutsch DG; Ueda N; Yamamoto S
    Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):201-10. PubMed ID: 12052036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological characterization of endocannabinoid transport and fatty acid amide hydrolase inhibitors.
    Dickason-Chesterfield AK; Kidd SR; Moore SA; Schaus JM; Liu B; Nomikos GG; Felder CC
    Cell Mol Neurobiol; 2006; 26(4-6):407-23. PubMed ID: 16736384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatty acid amide hydrolase inhibitors: a patent review (2009-2014).
    Lodola A; Castelli R; Mor M; Rivara S
    Expert Opin Ther Pat; 2015; 25(11):1247-66. PubMed ID: 26413912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and evaluation of paracetamol esters as novel fatty acid amide hydrolase inhibitors.
    Onnis V; Congiu C; Björklund E; Hempel F; Söderström E; Fowler CJ
    J Med Chem; 2010 Mar; 53(5):2286-98. PubMed ID: 20143779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anandamide externally added to lipid vesicles containing trapped fatty acid amide hydrolase (FAAH) is readily hydrolyzed in a sterol-modulated fashion.
    Kaczocha M; Lin Q; Nelson LD; McKinney MK; Cravatt BF; London E; Deutsch DG
    ACS Chem Neurosci; 2012 May; 3(5):364-8. PubMed ID: 22860204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arachidonoylserotonin and other novel inhibitors of fatty acid amide hydrolase.
    Bisogno T; Melck D; De Petrocellis L; Bobrov MYu ; Gretskaya NM; Bezuglov VV; Sitachitta N; Gerwick WH; Di Marzo V
    Biochem Biophys Res Commun; 1998 Jul; 248(3):515-22. PubMed ID: 9703957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical and biological properties of 4-(3-phenyl-[1,2,4] thiadiazol-5-yl)-piperazine-1-carboxylic acid phenylamide, a mechanism-based inhibitor of fatty acid amide hydrolase.
    Karbarz MJ; Luo L; Chang L; Tham CS; Palmer JA; Wilson SJ; Wennerholm ML; Brown SM; Scott BP; Apodaca RL; Keith JM; Wu J; Breitenbucher JG; Chaplan SR; Webb M
    Anesth Analg; 2009 Jan; 108(1):316-29. PubMed ID: 19095868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery and characterization of a highly selective FAAH inhibitor that reduces inflammatory pain.
    Ahn K; Johnson DS; Mileni M; Beidler D; Long JZ; McKinney MK; Weerapana E; Sadagopan N; Liimatta M; Smith SE; Lazerwith S; Stiff C; Kamtekar S; Bhattacharya K; Zhang Y; Swaney S; Van Becelaere K; Stevens RC; Cravatt BF
    Chem Biol; 2009 Apr; 16(4):411-20. PubMed ID: 19389627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemical and mutagenic investigations of fatty acid amide hydrolase: evidence for a family of serine hydrolases with distinct catalytic properties.
    Patricelli MP; Lovato MA; Cravatt BF
    Biochemistry; 1999 Aug; 38(31):9804-12. PubMed ID: 10433686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypic assessment of THC discriminative stimulus properties in fatty acid amide hydrolase knockout and wildtype mice.
    Walentiny DM; Vann RE; Wiley JL
    Neuropharmacology; 2015 Jun; 93():237-42. PubMed ID: 25698527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of computational methods to the design of fatty acid amide hydrolase (FAAH) inhibitors based on a carbamic template structure.
    Lodola A; Rivara S; Mor M
    Adv Protein Chem Struct Biol; 2011; 85():1-26. PubMed ID: 21920320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors.
    Moreira FA; Kaiser N; Monory K; Lutz B
    Neuropharmacology; 2008 Jan; 54(1):141-50. PubMed ID: 17709120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The endocannabinoid hydrolase FAAH is an allosteric enzyme.
    Dainese E; Oddi S; Simonetti M; Sabatucci A; Angelucci CB; Ballone A; Dufrusine B; Fezza F; De Fabritiis G; Maccarrone M
    Sci Rep; 2020 Feb; 10(1):2292. PubMed ID: 32041998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fatty acid amide hydrolase: biochemistry, pharmacology, and therapeutic possibilities for an enzyme hydrolyzing anandamide, 2-arachidonoylglycerol, palmitoylethanolamide, and oleamide.
    Fowler CJ; Jonsson KO; Tiger G
    Biochem Pharmacol; 2001 Sep; 62(5):517-26. PubMed ID: 11585048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ex vivo imaging of fatty acid amide hydrolase activity and its inhibition in the mouse brain.
    Glaser ST; Gatley SJ; Gifford AN
    J Pharmacol Exp Ther; 2006 Mar; 316(3):1088-97. PubMed ID: 16278311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevating endocannabinoid levels: pharmacological strategies and potential therapeutic applications.
    Pertwee RG
    Proc Nutr Soc; 2014 Feb; 73(1):96-105. PubMed ID: 24135210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Membrane lipids are key modulators of the endocannabinoid-hydrolase FAAH.
    Dainese E; De Fabritiis G; Sabatucci A; Oddi S; Angelucci CB; Di Pancrazio C; Giorgino T; Stanley N; Del Carlo M; Cravatt BF; Maccarrone M
    Biochem J; 2014 Feb; 457(3):463-72. PubMed ID: 24215562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.